Tristan Peitz

40 year

Finance

Consumer Services

Process Industries

Profile

Tristan Anthony Peitz worked as a Managing Director at Cohen Capital Management, Inc. (California) from 2010 to 2019.
He also served as an Independent Director at QSAM Biosciences, Inc. from 2017 to 2020.
Peitz received an undergraduate degree from the Stephen M.
Ross School of Business.

Former positions of Tristan Peitz

Companies	Position	End
QSAM BIOSCIENCES, INC.	Director/Board Member	09/12/2020
Cohen Capital Management, Inc. (California) Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals.	Portfolio Manager-Fixed Income	01/07/2019

See the detail of Tristan Peitz's experience

Training of Tristan Peitz

Stephen M. Ross School of Business

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tristan Peitz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Cohen Capital Management, Inc. (California) Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals.	Finance
QSAM Biosciences, Inc. QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX.	Process Industries